Drugs that target wakefulness, molecules in cannabis and wearable devices that modulate brain activity could help people with ...

The phase I study evaluates BAYRY's investigational GIRK4 inhibitor, BAY 3670549, for the treatment of patients with atrial ...

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.

LOS ANGELES -- The use of chemical restraint was more common among Black patients versus white and Hispanic patients in ...

A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by ...

Chronic pain affects more than 50 million Americans and remains one of the most difficult conditions to treat safely and effectively. While opioids have lo | Drug Discovery And Development ...